All the evidence indicated that the expression of PD-L1 and other immune inhibitory mechanisms in the glioma microenvironment might serve as negative feedback mechanisms that followed, rather than preceded, T cell activation and IFN-γ secretion. The gene discussed is CD274; the disease is glioma.